Angelman Syndrome Research

Research is key to improving the lives of individuals with Angelman syndrome and to finding a cure. In recent years, there have been critical discoveries that have greatly improved our understanding of Angelman syndrome. 

Watch Dr. Art Beaudet discuss the potential for a cure for Angelman syndrome.

As the largest non-governmental funder of Angelman syndrome-specific research, the Angelman Syndrome Foundation (ASF) has invested more than $9 million in Angelman syndrome research to date, supporting projects worldwide in the quest to find treatments for Angelman syndrome and ultimately a cure. Treatments resulting from the ASF’s $9 million investment in research help individuals with Angelman syndrome live better lives today and lead to better lives tomorrow, but require ongoing financial support.

Clinical Trials in Angelman Syndrome